Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
MDR3 and BSEP liver immunostaining, and analysis of biliary lipid composition should help to select PFIC candidates for whom genotyping could be proposed to confirm the diagnosis.
|
23141890 |
2012 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
|
18395098 |
2008 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
We conclude that 4PB therapy would have a therapeutic effect in patients with progressive familial intrahepatic cholestasis type 2 who retain transport activity of BSEP per se.
|
24530123 |
2014 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
When examined in model cell lines, genetic mutations in the BSEP gene impair its targeting and transport function, contributing to the pathogenesis of progressive familial intrahepatic cholestasis type II (PFIC II).
|
18798335 |
2008 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
In progressive familial intrahepatic cholestasis type 2 (PFIC-2), severe steatorrhea is often documented.
|
16641580 |
2006 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
oligonucleotide array CGH identified intragenic exonic deletions in 2 cases: a heterozygous single-exon deletion of 4.5 kb in the SLC25A13 gene [solute carrier family 25, member 13 (citrin)] in an individual with citrin deficiency and a homozygous 10.5-kb deletion of exons 13-17 in the ABCB11 gene [PFIC2, ATP-binding cassette, sub-family B (MDR/TAP), member 11] in a patient with progressive familial intrahepatic cholestasis.
|
18487280 |
2008 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is an autosomal recessive disease due to mutations in ABCB11.
|
25085279 |
2014 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Mutation of the ABCB11 gene encoding BSEP induces BSEP deficiency and progressive familial intrahepatic cholestasis type 2 (PFIC2).
|
28150711 |
2017 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Progressive familial intrahepatic cholestasis types 2 and 3 involve the canalicular bile salt export pump and a phospholipid translocase, respectively, both of which are fundamental to bile secretion.
|
15946126 |
2005 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Progressive familial intrahepatic cholestasis (PFIC) with normal serum levels of gamma-glutamyltranspeptidase can result from mutations in ATP8B1 (encoding familial intrahepatic cholestasis 1 [FIC1]) or ABCB11 (encoding bile salt export pump [BSEP]).
|
20447715 |
2010 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive cholestatic diseases of childhood and represents the main indication for liver transplantation at this age; PFIC2 involves ABCB11 gene, that encodes the ATPdependent canalicular bile salt export pump (BSEP).
|
27493120 |
2017 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the bile salt export pump (BSEP) or the multidrug resistance P-glycoprotein 3 (MDR3) are linked to impaired bile salt homeostasis and lead to progressive familial intrahepatic cholestasis (PFIC)-2 and -3, respectively.
|
15841457 |
2005 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ABCB11, the gene encoding BSEP, induce progressive familial intrahepatic cholestasis type 2 (PFIC2), which presents with severe jaundice and liver dysfunction.
|
29507376 |
2018 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We reviewed the explant livers of seven children with metabolic disorders [ornithine-transcarbamylase deficiency (one), coagulation factor VII deficiency (three), Crigler-Najjar syndrome (one), progressive familial intrahepatic cholestasis type 2 (PFIC-2) deficiency (two)] who received allograft hepatocytes by intraportal infusion with improvement in phenotype, although all later underwent liver transplantation (LT).
|
19364077 |
2008 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Novel ABCB11 mutations in a Thai infant with progressive familial intrahepatic cholestasis.
|
19750581 |
2009 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Mutations in BSEP are associated with cholestatic diseases such as progressive familial intrahepatic cholestasis type 2 (PFIC2), benign recurrent intrahepatic cholestasis type 2 (BRIC2), drug-induced cholestasis, and intrahepatic cholestasis of pregnancy.
|
23685087 |
2014 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We report on NR1H4 analysis in eight patients with progressive familial intrahepatic cholestasis (PFIC) and in eight women with either ICP and/or drug-induced cholestasis (DIC) in whom no disease causing mutation in ATP8B1, ABCB11 and/or ABCB4 were found.
|
23142591 |
2012 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding the canalicular bile salt export pump (BSEP) can result in progressive familial intrahepatic cholestasis type 2 (PFIC-2).
|
25847799 |
2015 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.
|
27239116 |
2016 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Over 150 BSEP mutations are associated with progressive familial intrahepatic cholestasis type 2 (PFIC-2), with few characterised specifically.
|
27114171 |
2016 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
|
20232290 |
2010 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
ABCB11 gene mutations play an important role in Chinese patients with progressive intrahepatic cholestasis and low GGT.
|
19845854 |
2010 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
We report on the first case of a child with PFIC-2 suffering from repeated posttransplant recurrence of progressive intrahepatic cholestasis due to autoantibodies against BSEP.
|
19642168 |
2009 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Additionally, rare monogenetic diseases exist which can be explained by absence of function or dysfunction of specific hepatic transporters, such as progressive familial intrahepatic cholestasis type 2 by genetic modifications in BSEP that lead to a loss of transporter function.
|
31004787 |
2020 |
Progressive intrahepatic cholestasis (disorder)
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|